Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2025-12-24 @ 5:37 PM
NCT ID:
NCT02874768
Eligibility Criteria:
Inclusion Criteria:
* non-emergent major abdominal surgery with ICU admission
* the need of sedation during ICU stay
Exclusion Criteria:
* age younger than 20 years and older than 89 years
* refractory bradycardia (HR \< 60 bpm after treatment)
* severe AV block (2nd or 3rd degree)
* refractory shock (MAP \< 60 mm Hg after treatment)
* severe heart failure or NYHA 4
* new onset of myocardial infarction within 4 weeks
* receive CPR within 4 weeks
* APACHE score \> 30 before enrollment
* severe liver cirrhosis or CHILD B or C
* pregnancy
* allergic history to dexmedetomidine or propofol
* be enrolled in other clinical trials related to dexmedetomidine or propofol within 4 weeks
* non-native speakers
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
89 Years
Study:
NCT02874768
Study Brief:
Protocol Section:
NCT02874768